Literature DB >> 25177617

Expression of Bcl-2 and MIB-1 Markers in Oral Squamous Cell Carcinoma (OSCC)- A Comparative Study.

Jessica Garewal1, Ripin Garewal2, Keya Sircar3.   

Abstract

BACKGROUND: Neoplasia results from various genetic and epigenetic factors. Our study focused on the pathogenesis which involved an imbalance in various molecular mechanisms which regulated cell proliferation and apoptosis. The anti-apoptotic mechanism is regulated by Bcl-2 gene, while Ki-67 is expressed exclusively in nuclei of proliferating cells. This study was done to evaluate the basic pathologic process which underlay well and poorly differentiated oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: Thirty cases of oscc were selected, out of which 11 were well differentiated, 9 were moderately differentiated and 10 were poorly differentiated. Three slides of 4μm thickness were prepared out of each sample, which were then subjected to Hematoxylin and eosin stain (H&E) staining and two types of immunohistochemical (IHC) staining. Immunohistochmical markers used were Ki-67 (proliferative marker using MIB-1 (Molecular Immunology Borstel 1) antibody) and Bcl-2 (anti-apoptotic marker). The number of MIB-1 and Bcl-2 positive cells was calculated from ten different high power fields, by counting the number of positive cells per 50 cells in each field, by making a grid pattern. The overall percentage value for each case was evaluated for MIB-1 and Bcl-2 positive cells. Karl-Pearson's co-relation coefficient was calculated between MIB-1 and Bcl-2 in each group. The aim of this study was to co-relate the expression of Ki-67, a proliferative marker, by using MIB-1 antibody and Bcl-2, an anti-apoptotic marker in various grades of oscc and also to determine whether there was any co-relation between these two markers in the 30 cases of oscc .
RESULTS: A statistically significant increase for MIB-1 and a statistically significant decrease for Bcl-2 was found in well to moderately to poorly differentiated Squamous cell carcinoma (SCC). A statistically significant co-relation was also found between MIB-1 and Bcl-2 in poorly differentiated oscc .
CONCLUSION: MIB-1 expression is predominant in well, moderate and poorly differentiated SCCs. Bcl-2 expression is predominant in well differentiated than in moderately and poorly differentiated oscc , which suggested that apoptosis probably played a major role in the early stages of carcinogenesis.

Entities:  

Keywords:  Bcl-2; MIB-1; Squamous cell carcinoma

Year:  2014        PMID: 25177617      PMCID: PMC4149123          DOI: 10.7860/JCDR/2014/6474.4562

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.

Authors:  J Gerdes
Journal:  Semin Cancer Biol       Date:  1990-06       Impact factor: 15.707

2.  Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.

Authors:  R C Jordan; G C Catzavelos; A W Barrett; P M Speight
Journal:  Eur J Cancer B Oral Oncol       Date:  1996-11

3.  Molecular analysis of oral squamous cell carcinoma: a tissue microarray study.

Authors:  M C Solomon; S Carnelio; V Gudattu
Journal:  Indian J Cancer       Date:  2010 Apr-Jun       Impact factor: 1.224

4.  The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.

Authors:  X Xie; O P Clausen; P De Angelis; M Boysen
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

5.  Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.

Authors:  L L Loro; O K Vintermyr; P G Liavaag; R Jonsson; A C Johannessen
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

6.  Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.

Authors:  N Zidar; N Gale; A Cör; V Kambic
Journal:  J Laryngol Otol       Date:  1996-05       Impact factor: 1.469

7.  Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.

Authors:  S Staibano; M D Mignogna; L Lo Muzio; L Di Alberti; E Di Natale; A Lucariello; E Mezza; E Bucci; G DeRosa
Journal:  Hum Pathol       Date:  1998-11       Impact factor: 3.466

8.  Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.

Authors:  Juan Carlos de Vicente; Luis Manuel Junquera Gutiérrez; Agustín Herrero Zapatero; Manuel Florentino Fresno Forcelledo; Gonzalo Hernández-Vallejo; Juan Sebastián López Arranz
Journal:  Head Neck       Date:  2004-01       Impact factor: 3.147

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

10.  Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma.

Authors:  Nidhi Dwivedi; Shaleen Chandra; Bina Kashyap; Vineet Raj; Akhil Agarwal
Journal:  Contemp Clin Dent       Date:  2013-01
View more
  2 in total

1.  Differential Expression of Potential Biomarkers of Oral Squamous Cell Carcinoma Development.

Authors:  Paola Fernandes Pansini; Isabella Bittencourt do Valle; Thabata Coeli Dias Damasceno; Priscila Marinho de Abreu; Anna Clara Gregório Có; Rossana Verónica Mendoza López; Jeferson Lenzi; Ricardo Mai Rocha; Evandro Duccini Souza; Maria Paula Curado; Hisham Mehanna; Paul Nankivell; José Roberto Vasconcelos de Podestá; Sandra Ventorin von Zeidler
Journal:  Head Neck Pathol       Date:  2021-04-11

2.  Possible Role of Bcl-2 Expression in Metastatic and Non Metastatic Oral Squamous Cell Carcinoma.

Authors:  V Pavithra; Karuna Kumari; Vanishri C Haragannavar; Roopa S Rao; Shwetha Nambiar; Dominic Augustine; S V Sowmya
Journal:  J Clin Diagn Res       Date:  2017-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.